发明名称 RECOMBINANT MODIFIED VIRUS OF VACCINE ANKARA ABLE TO EXPRESS HEPATITIS C VIRUS STRUCTURAL ANTIGENS
摘要 FIELD: genetic engineering, virology, pharmacy. ^ SUBSTANCE: invention proposes the recombinant modified virus OF VACCINE Ankara able to express structural antigens of hepatitis C virus. Virus comprises DNA sequences encoding structural antigens of hepatitis C virus or their functional regions or epitopes of hepatitis C virus structural antigens. Also, invention proposes a pharmaceutical composition comprising such virus, eucaryotic cell infected with such virus, a method for preparing such virus and a method for preparing hepatitis C virus structural polypeptides. Invention can be used in virology and medicine for preparing hepatitis C virus antigen. ^ EFFECT: valuable properties of virus. ^ 20 cl, 14 dwg, 1 tbl
申请公布号 RU2270860(C2) 申请公布日期 2006.02.27
申请号 RU20040106592 申请日期 2002.09.05
申请人 发明人 ZUTTER GERD;EHRFLE VOLKER;SHTAJB KAROLIN;VAN JUAN';LI GUANDI;CHZHU LISIN'
分类号 C12N7/01;C12N15/09;A61K39/29;A61P1/16;A61P31/12;A61P31/14;A61P35/00;A61P37/04;C12N5/10;C12N7/04;C12N15/39;C12N15/51;C12N15/863;C12P21/02 主分类号 C12N7/01
代理机构 代理人
主权项
地址